The global bronchoscopes market was valued at USD 3.46 billion in 2025 and is projected to reach USD 8.03 billion by 2034, expanding at a CAGR of 9.8% during the forecast period from 2026 to 2034. Demand for minimally invasive respiratory procedures, improvements in bronchoscopic imaging, and the need for accurate lung cancer diagnosis are shaping the market. North America held the largest regional share in 2025, while Asia Pacific is expected to record the fastest growth over the forecast period.
Key Market Highlights
Market Size (2025): USD 3.46 billion
Market Size (2026): USD 3.80 billion
CAGR (Forecast Period): 9.8% from 2026 to 2034
Forecast Year: 2034
Projected Market Size (Forecast Year): USD 8.03 billion
Dominant Region: North America
Fastest-Growing Region: Asia Pacific
Bronchoscopes are medical instruments that allow clinicians to examine the airways and lungs, collect tissue samples, and perform selected diagnostic and therapeutic procedures. Available in flexible and rigid designs, these devices support the investigation of lung cancer, airway abnormalities, and other respiratory conditions. Hospitals and specialist respiratory centres rely on bronchoscopy to obtain diagnostic information while limiting the need for more invasive procedures.
Technological developments are expanding the role of bronchoscopes in modern respiratory care. Flexible instruments offer access to different airway structures, while disposable devices address infection-control requirements. Robotic navigation and real-time imaging are also helping clinicians locate small lung nodules and guide tissue sampling with greater precision.
The need for early lung cancer diagnosis is a major factor supporting demand for bronchoscopes. The International Agency for Research on Cancer reported approximately 2.6 million new lung cancer cases worldwide in 2024, highlighting the substantial need for effective diagnostic services. Bronchoscopy allows clinicians to inspect suspicious areas and collect samples for laboratory examination, supporting diagnosis and treatment planning.
Medical device supply networks also influence market access. Manufacturers and distributors provide bronchoscopes, accessories, and replacement components to hospitals and pulmonary care facilities. Reliable availability helps healthcare providers maintain diagnostic services and manage equipment requirements.
The adoption of advanced bronchoscopes can be constrained by equipment costs, maintenance requirements, and the need for trained clinical professionals. Hospitals must also consider reprocessing procedures for reusable instruments and infection-control protocols for each procedure. These operational requirements can affect purchasing decisions, particularly in facilities with limited budgets or specialized respiratory care resources.
The market presents opportunities in single-use bronchoscopes, pediatric instruments, and robotic bronchoscopy systems. Disposable devices can help healthcare facilities reduce cross-contamination risks, while smaller instruments address the needs of pediatric patients and procedures involving narrow airways. Real-time imaging and robotic navigation also create opportunities for manufacturers developing technologies that improve access to peripheral lung nodules and support accurate tissue sampling.
By product, flexible bronchoscopes are projected to register a CAGR of 9.16% during 2026–2034, reflecting their versatility across diagnostic and therapeutic procedures. By usage, disposable bronchoscopes are expected to record the fastest growth, with a CAGR of 11.24%, as healthcare providers prioritize infection prevention and procedural efficiency.
By application, oncology dominated the market with a 31.6% share in 2025, reflecting the role of bronchoscopes in lung cancer diagnosis and tissue collection. Among end users, hospitals held the leading position with a 68.5% share in 2025. However, ambulatory surgical centres are expected to register the fastest growth, at a CAGR of 9.67%, as outpatient diagnostic and therapeutic services gain importance.
North America dominated the bronchoscopes market with a 38.4% share in 2025. Established healthcare infrastructure, specialized pulmonary services, and the adoption of advanced diagnostic equipment contribute to the region's leading position. Demand for accurate lung disease diagnosis and infection-control solutions also supports the use of flexible and disposable bronchoscopes.
Asia Pacific is projected to be the fastest-growing region, with a CAGR of 10.46% during 2026–2034. Healthcare infrastructure development, greater access to specialized respiratory services, and the adoption of minimally invasive diagnostic technologies are creating opportunities across regional markets. Europe accounted for 27.6% of the global market in 2025 and is expected to register a CAGR of 7.94% during the forecast period.
The bronchoscopes market includes established medical technology companies, endoscopy specialists, and manufacturers of single-use devices. Competition centres on imaging quality, instrument flexibility, product reliability, infection prevention, and clinical support. Leading companies identified in the market include:
Olympus Corporation
FUJIFILM Holdings Corporation
Ambu A/S
KARL STORZ SE & Co. KG
Boston Scientific Corporation
Companies are focusing on product development and specialized designs to address different clinical requirements. Disposable technologies and advanced visualization systems remain important areas of competition as healthcare providers evaluate procedural performance, safety, and operating costs.
In February 2026, Olympus announced FDA-cleared pediatric use for a single-use bronchoscope with a 2.2 mm distal end for children aged 6 months to 6 years. The company also announced a model with a 3.2 mm distal end and a 1.2 mm working channel for older children. This development highlights the industry's focus on smaller instruments for specialized respiratory procedures.
Additionally, a 2026 multicentre study published in Thorax reported 99.4% tool-in-lesion confirmation and an 89% diagnostic yield across 155 patients undergoing robotic bronchoscopy for suspicious peripheral lung nodules measuring 20 mm or smaller. These findings highlight the potential of real-time targeting technologies in lung biopsy procedures.
Click Here to Access the Comprehensive Report: https://straitsresearch.com/report/bronchoscopes-market
The bronchoscopes market is expected to benefit from continued demand for lung cancer diagnosis, minimally invasive procedures, and improved respiratory care. Flexible and disposable instruments, pediatric applications, and robotic bronchoscopy are likely to remain important areas of development. Manufacturers that combine effective visualization, reliable performance, and practical infection-control solutions may be well positioned to address changing clinical needs through 2034.
Straits Research is a global market intelligence and consulting company that provides market research, business insights, and strategic analysis across diverse industries. The company helps businesses understand market dynamics, evaluate emerging opportunities, and make informed decisions through data-driven research and industry analysis.